Verastem, Inc. Amortization of Intangible Assets
Verastem, Inc. (VSTM) reported Amortization of Intangible Assets of $559.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- Verastem, Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $280.00K.
- Verastem, Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $279.00K.
- Verastem, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $280.00K.
- Verastem, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $290.00K.
- Verastem, Inc. amortization of intangible assets for fiscal 2025 was $698.00K.
- Verastem, Inc. amortization of intangible assets for fiscal 2020 was $793.00K, a 49.46% decline from fiscal 2019.
- Verastem, Inc. amortization of intangible assets for fiscal 2019 was $1.57M, a 270.92% increase from fiscal 2018.
- Verastem, Inc. amortization of intangible assets for fiscal 2018 was $423.00K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $280.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $559.00K 10-Q · filed 2026-08-06 | $839.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $279.00K 10-Q · filed 2026-05-07 | $559.00K derived: sum of 2 quarters · filed 2026-05-07 | $849.00K derived: sum of 3 quarters · filed 2026-05-07 | |
| 2025-12-31 | $280.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $570.00K derived: sum of 2 quarters · filed 2026-03-04 | $698.00K 10-K · filed 2026-03-04 | |
| 2025-09-30 | $290.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $418.00K 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | $128.00K 10-Q · filed 2026-08-06 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $100.00K derived: sum of 2 quarters · filed 2023-03-14 | $500.00K derived: sum of 3 quarters · filed 2023-03-14 | $793.00K 10-K · filed 2023-03-14 |
| 2020-09-30 | $100.00K 10-Q · filed 2020-11-09 | $500.00K derived: sum of 2 quarters · filed 2020-11-09 | $793.00K 10-Q · filed 2021-11-04 | $1.28M derived: sum of 4 quarters · filed 2022-03-28 |
| 2020-06-30 | $400.00K 10-Q · filed 2020-08-10 | $785.00K 10-Q · filed 2021-08-02 | $1.18M derived: sum of 3 quarters · filed 2022-03-28 | $1.58M derived: sum of 4 quarters · filed 2022-03-28 |
| 2020-03-31 | $392.00K 10-Q · filed 2021-05-11 | $784.00K derived: sum of 2 quarters · filed 2022-03-28 | $1.18M derived: sum of 3 quarters · filed 2022-03-28 | $1.58M derived: sum of 4 quarters · filed 2022-03-28 |
| 2019-12-31 | $392.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $792.00K derived: sum of 2 quarters · filed 2022-03-28 | $1.19M derived: sum of 3 quarters · filed 2022-03-28 | $1.57M 10-K · filed 2022-03-28 |
| 2019-09-30 | $400.00K 10-Q · filed 2019-10-30 | $800.00K derived: sum of 2 quarters · filed 2019-10-30 | $1.18M 10-Q · filed 2020-11-09 | $1.58M derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-06-30 | $400.00K 10-Q · filed 2019-08-01 | $785.00K 10-Q · filed 2020-08-10 | $1.18M derived: sum of 3 quarters · filed 2020-05-07 | $1.22M derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-03-31 | $392.00K 10-Q · filed 2020-05-07 | $784.00K derived: sum of 2 quarters · filed 2020-05-07 | $815.00K derived: sum of 3 quarters · filed 2020-05-07 | |
| 2018-12-31 | $392.00K 10-K · filed 2019-03-12 | $423.00K derived: sum of 2 quarters · filed 2019-03-12 | $423.00K 10-K · filed 2021-03-18 | |
| 2018-09-30 | $31.00K 10-K · filed 2019-03-12 | $31.00K 10-Q · filed 2019-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |